PubMed ID: 38728357 Author(s): Xie Z, Zhang T, Kim S, Lu J, Zhang W, Lin CH, Wu MR, Davis A, Channa R, Giancardo L, Chen H, Wang S, Chen R, Zhi D. iGWAS: Image-based genome-wide …
All Posts
The retina’s neurovascular unit: Müller glial sheaths and neuronal contacts.
PubMed ID: 38903067 Author(s): Grimes WN, Berson DM, Sabnis A, Hoon M, Sinha R, Tian H, Diamond JS. The retina’s neurovascular unit: Muller glial sheaths and neuronal contacts. bioRxiv [Preprint]. 2024 May 1:2024.04.30.591885. doi: 10.1101/2024.04.30.591885. …
An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation.
PubMed ID: 38635428 Author(s): Weinlander E, Erb B, Thiessen C. An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation. Am J Bioeth. 2024 May;24(5):75-79. doi: 10.1080/15265161.2024.2328285. Epub 2024 Apr 18. No abstract …
Re: “Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections”.
PubMed ID: 38738715 Author(s): Gokharu S, Rehman O, Das S. Re: “Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections”. Ophthalmic Plast Reconstr Surg. 2024 May-Jun 01;40(3):357-358. doi: 10.1097/IOP.0000000000002680. Epub 2024 May …
Conjunctival nodule as a primary manifestation of disseminated histoplasmosis.
PubMed ID: 39132106 Author(s): Narula CG, Gandhi A, Das S. Conjunctival nodule as a primary manifestation of disseminated histoplasmosis. Oman J Ophthalmol. 2024 Jun 27;17(2):275-277. doi: 10.4103/ojo.ojo_158_23. eCollection 2024 May-Aug. PMID 39132106 Journal: Oman Journal …
Safety and Efficacy of Brolucizumab in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
PubMed ID: 37849309 Author(s): Abu Serhan H, Taha MJJ, Abuawwad MT, Abdelaal A, Irshaidat S, Abu Serhan L, Abu Salim QF, Awamleh N, Abdelazeem B, Elnahry AG. Safety and Efficacy of Brolucizumab in the Treatment …
The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.
PubMed ID: 38652153 Author(s): Abu Serhan H, Abu Suilik H, Hassan AK, AlSamhori JF, Hassan AR, Siddiq A, Ahmed N, Elnahry AG. The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review. Int …
DOVS at ARVO 2024
The UW Department of Ophthalmology and Visual Sciences is pleased to have many colleagues presenting and participating at this year’s Association for Research in Vision and Ophthalmology annual meeting in New Orleans, Louisiana.
Nanoparticles subdue antibiotic-resistant bacteria’s defences while enhancing innate immunity
A method for overcoming antibiotic resistance uses multimodal nanoparticles that target bacterial defence mechanisms while enhancing the innate immune response. The rise in antibiotic resistance is considered a slow-moving medical catastrophe, as these revolutionary drugs that have kept us relatively safe from bacterial infection for decades are losing their efficacy. In part due to their co-evolution, bacterial pathogens have developed mechanisms to resist almost every antibiotic on the market and we are in desperate need for new, innovative approaches. Writing in Nature Nanotechnology, Zhu et al. present a nanoparticle-based possibility, in which they target bacterial defence mechanisms while simultaneously enhancing the ability of the host immune cells to fight infection.